company:novo-nordisk Novo's Amycretin delivers great Phase 2 results Novo Nordisk's Amycretin produces stellar results in Phase 2 trials -- we dive into Amycretin and other new drugs to see how it compares.
drug:amycretin Novo's new GLP1: Amycretin Novo has a new drug it's working on -- Amycretin. Amycretin is a dual agonist, with the *new* agonist being Amylin. Read more about it here.
